ELTP
ELITE PHARMACEUTICALS INC /NV/
Key Financials
Operating Income
$19.6M
↑ 81.7%
Net Income
$-4314659
↓ 121.5%
Revenue
$84.0M
↑ 48.4%
Gross Profit
$40.1M
↑ 52.1%
EPS (Diluted)
$0.00
↓ 100.0%
Total Assets
$96.4M
↑ 15.2%
Cash & Equivalents
$7.1M
↓ 9.3%
Shareholders' Equity
$53.5M
↓ 7.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 4/2/2026 | View on SEC |
| 8-K | 2/17/2026 | View on SEC |
| 10-Q | 2/17/2026 | View on SEC |
| 8-K | 2/11/2026 | View on SEC |
| 4 | 1/13/2026 | View on SEC |
| 8-K | 11/14/2025 | View on SEC |
| 10-Q | 11/14/2025 | View on SEC |
| 8-K/A | 11/12/2025 | View on SEC |
| 8-K | 11/12/2025 | View on SEC |
| 8-K | 11/10/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ELTP |
| Company Name | ELITE PHARMACEUTICALS INC /NV/ |
| CIK | 1053369 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0331 |
| State of Incorporation | NJ |
| Phone | 2017502646 |